ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Amyris, a producer of fermentation-derived ingredients, says it has scaled up production of cannabigerol (CBG), a cannabinoid that can be used in skin-care and cosmetic products. CBG is the precursor of two more famous cannabinoids: cannabidiol (CBD) and tetrahydrocannabinol (THC). Like CBD, CBG does not produce a high but may have therapeutic benefits. Amyris says its yeast-fermentation route is less costly than extracting the compound from plants. The firm expects to begin sales this year.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X